The most frequently mutated genes, in agreement with other large AML studies [12, 13], were FLT3 (33% of subjects), NPM1 (32%), NRAS (30%), and DNMT3A (25%) (Fig. 1). The gene discussed is NPM1; the disease is acute myeloid leukemia.